Sleep attacks in patients receiving dopamine-receptor agonists

The dopamine-receptor agonists (DAs) pramipexole, ropinirole, and pergolide are commonly used in the treatment of Parkinson’s disease (PD) and restless leg syndrome (RLS). In 1999, the Institute for Safe Medication Practices warned that pramipexole had been associated with reports of falling